An unexpected drug-drug interaction has been recently reported between dolutegravir, an HIV integrase inhibitor, and valproic acid. Despite there being several potential underlying mechanisms, plasma protein displacement has been suggested. The aim of this study was to assess plasma concentrations of several antiretrovirals when administered with or without valproic acid.

Antiretroviral concentrations in the presence and absence of valproic acid

Calcagno, A
First
;
Cusato, J;Ferrara, M;De Nicolò, A;Lazzaro, A;Manca, A;D'Avolio, A;Di Perri, G;Bonora, S
Last
2020

Abstract

An unexpected drug-drug interaction has been recently reported between dolutegravir, an HIV integrase inhibitor, and valproic acid. Despite there being several potential underlying mechanisms, plasma protein displacement has been suggested. The aim of this study was to assess plasma concentrations of several antiretrovirals when administered with or without valproic acid.
175
7
1969
1971
Calcagno, A; Cusato, J; Ferrara, M; De Nicolò, A; Lazzaro, A; Manca, A; D'Avolio, A; Di Perri, G; Bonora, S
File in questo prodotto:
File Dimensione Formato  
ARVs VPA Calcagno JAC 2020.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 315.61 kB
Formato Adobe PDF
315.61 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1749109
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact